Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease

Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Although MASLD has been widely studied in persons with Type 2 diabetes (T2D), far less in known about the path...

Full description

Saved in:
Bibliographic Details
Main Authors: Adeyinka Taiwo, Ronald A. Merrill, Linder Wendt, Daniel Pape, Himani Thakkar, J. Alan Maschek, James Cox, Scott A. Summers, Bhagirath Chaurasia, Nikitha Pothireddy, Bianca B. Carlson, Antonio Sanchez, Patrick Ten Eyck, Diana Jalal, Ayotunde Dokun, Eric B. Taylor, William I. Sivitz
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Endocrinology
Subjects:
NAFLD
MASLD
NASH
MASH
Type 1 diabetes
Type 2 diabetes
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1500242/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2025.1500242/full

Similar Items